Seoul, South Korea

Yong-Seo Cho


Average Co-Inventor Count = 31.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yong-Seo Cho: Innovator in Neurodegenerative Disease Treatment

Introduction

Yong-Seo Cho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patent developments. His work focuses on creating novel compounds that can aid in the prevention and treatment of various brain diseases.

Latest Patents

Yong-Seo Cho holds a patent for "Benzoarylureido compounds, and composition for prevention or treatment of neurodegenerative brain disease containing the same." This patent presents novel benzoarylureido compounds and their applications in preventing and treating neurodegenerative brain diseases. The diseases addressed in his patent include Alzheimer's disease, dementia, Parkinson's disease, stroke, amyloidosis, Pick's disease, Lou Gehrig's disease, Huntington's disease, and Creutzfeldt-Jakob disease. He has 1 patent to his name.

Career Highlights

Yong-Seo Cho is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work has garnered attention for its potential impact on treating debilitating brain diseases that affect millions worldwide. His innovative approach to developing therapeutic compounds showcases his commitment to advancing medical science.

Collaborations

Some of his notable coworkers include Hoh-Gyu Hahn and Kee-Dal Nam. Their collaborative efforts contribute to the ongoing research and development in the field of neurodegenerative diseases.

Conclusion

Yong-Seo Cho's contributions to the field of neurodegenerative disease treatment through his innovative patents highlight the importance of research in improving health outcomes. His work continues to inspire advancements in medical science and offers hope for those affected by these challenging conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…